The alveolar epithelium serves as a barrier between organism and environment and functions as the first line of protection against potential respiratory pathogens. Alveolar type II (TII) cells have traditionally been considered the immune cells of the alveolar epithelium, as they possess immunomodulatory functions; however, the precise role of alveolar type I (TI) cells, which comprise ~95% of the alveolar epithelial surface area, in lung immunity is not clear. We sought to determine if there was a difference in the response of TI and TII cells to lung injury and if TI cells could actively participate in the alveolar immune response. TI cells isolated via fluorescence activated cell sorting (FACS) from LPS-injured rats demonstrated greater fold-induction of multiple inflammatory mediators than TII cells isolated in the same manner from the same animals. Levels of the cytokines TNF-α, IL-6 and IL-1β from cultured primary rat TI cells after LPS stimulation were significantly increased compared to similarly studied primary rat TII cells. We found that contrary to published reports, cultured TII cells produce relatively small amounts of TNF-α, IL-6 and IL-1β after LPS treatment; the higher levels of cytokine expression from cultured TII cells reported in the literature were likely from macrophage contamination due to traditional non-FACS TII cell isolation methods. Co-culture of TII cells with macrophages prior to LPS stimulation increased TNF-α and IL-6 production to levels reported by other investigators for TII cells, however, co-culture of TI cells and macrophages prior to LPS treatment resulted in marked increases in TNF-α and IL-6 production. Finally, exogenous surfactant blunted the IL-6 response to LPS in cultured TI cells. Taken together, these findings advocate a role for TI cells in the innate immune response and suggest that both TI and TII cells are active players in host defense mechanisms in the lung.
References
[1]
Fehrenbach H (2001) Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2: 33–46.
[2]
Paine R 3rd, Rolfe MW, Standiford TJ, Burdick MD, Rollins BJ, et al. (1993) MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol 150: 4561–4570.
[3]
Vanderbilt JN, Mager EM, Allen L, Sawa T, Wiener-Kronish J, et al. (2003) CXC chemokines and their receptors are expressed in type II cells and upregulated following lung injury. Am J Respir Cell Mol Biol 29: 661–668.
Wright JR (2004) Host defense functions of pulmonary surfactant. Biol Neonate 85: 326–332.
[6]
Tenner AJ, Robinson SL, Borchelt J, Wright JR (1989) Human pulmonary surfactant protein (SP-A), a protein structurally homologous to C1q, can enhance FcR- and CR1-mediated phagocytosis. J Biol Chem 264: 13923–13928.
[7]
Borron P, McIntosh JC, Korfhagen TR, Whitsett JA, Taylor J, et al. (2000) Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 278: L840–847.
[8]
Stone KC, Mercer RR, Freeman BA, Chang LY, Crapo JD (1992) Distribution of lung cell numbers and volumes between alveolar and nonalveolar tissue. Am Rev Respir Dis 146: 454–456.
[9]
Wong MH, Chapin OC, Johnson MD (2012) LPS-stimulated cytokine production in type I cells is modulated by the renin-angiotensin system. Am J Respir Cell Mol Biol 46: 641–650.
[10]
Crestani B, Cornillet P, Dehoux M, Rolland C, Guenounou M, et al. (1994) Alveolar type II epithelial cells produce interleukin-6 in vitro and in vivo. Regulation by alveolar macrophage secretory products. J Clin Invest 94: 731–740.
[11]
Kanj RS, Kang JL, Castranova V (2005) Measurement of the release of inflammatory mediators from rat alveolar macrophages and alveolar type II cells following lipopolysaccharide or silica exposure: a comparative study. J Toxicol Environ Health A 68: 185–207.
[12]
McRitchie DI, Isowa N, Edelson JD, Xavier AM, Cai L, et al. (2000) Production of tumour necrosis factor alpha by primary cultured rat alveolar epithelial cells. Cytokine 12: 644–654.
[13]
Rubins JB (2003) Alveolar macrophages: wielding the double-edged sword of inflammation. Am J Respir Crit Care Med 167: 103–104.
[14]
Moxley MA, Baird TL, Corbett JA (2000) Adoptive transfer of acute lung injury. Am J Physiol Lung Cell Mol Physiol 279: L985–993.
[15]
Gonzalez RF, Allen L, Dobbs LG (2009) Rat alveolar type I cells proliferate, express OCT-4, and exhibit phenotypic plasticity in vitro. Am J Physiol Lung Cell Mol Physiol 297: L1045–1055.
[16]
Gonzalez RF, Dobbs LG (1998) Purification and analysis of RTI40, a type I alveolar epithelial cell apical membrane protein. Biochim Biophys Acta 1429: 208–216.
[17]
Gutierrez JA, Gonzalez RF, Dobbs LG (1998) Mechanical distension modulates pulmonary alveolar epithelial phenotypic expression in vitro. Am J Physiol 274: L196–202.
[18]
Wang S, Hubmayr RD (2011) Type I alveolar epithelial phenotype in primary culture. Am J Respir Cell Mol Biol 44: 692–699.
[19]
Dobbs LG (1990) Isolation and culture of alveolar type II cells. Am J Physiol 258: L134–147.
[20]
Bligh EG, Dyer WJ (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911–917.
[21]
Ledeboer A, Binnekade R, Breve JJ, Bol JG, Tilders FJ, et al. (2002) Site-specific modulation of LPS-induced fever and interleukin-1 beta expression in rats by interleukin-10. Am J Physiol Regul Integr Comp Physiol 282: R1762–1772.
[22]
van der Windt GJ, Hoogendijk AJ, Schouten M, Hommes TJ, de Vos AF, et al. (2011) Osteopontin impairs host defense during pneumococcal pneumonia. J Infect Dis 203: 1850–1858.
[23]
Denhardt DT, Guo X (1993) Osteopontin: a protein with diverse functions. FASEB J 7: 1475–1482.
[24]
O'Regan AW, Nau GJ, Chupp GL, Berman JS (2000) Osteopontin (Eta-1) in cell-mediated immunity: teaching an old dog new tricks. Immunol Today 21: 475–478.
[25]
Takahashi F, Takahashi K, Shimizu K, Cui R, Tada N, et al. (2004) Osteopontin is strongly expressed by alveolar macrophages in the lungs of acute respiratory distress syndrome. Lung 182: 173–185.
[26]
Contento RL, Molon B, Boularan C, Pozzan T, Manes S, et al. (2008) CXCR4-CCR5: a couple modulating T cell functions. Proc Natl Acad Sci U S A 105: 10101–10106.
[27]
Gulick RM, Lalezari J, Goodrich J, Clumeck N, DeJesus E, et al. (2008) Maraviroc for previously treated patients with R5 HIV-1 infection. N Engl J Med 359: 1429–1441.
[28]
Thorley AJ, Ford PA, Giembycz MA, Goldstraw P, Young A, et al. (2007) Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages. J Immunol 178: 463–473.
[29]
Zhang F, Wang X, Wang W, Li N, Li J (2008) Glutamine reduces TNF-alpha by enhancing glutathione synthesis in lipopolysaccharide-stimulated alveolar epithelial cells of rats. Inflammation 31: 344–350.
[30]
Dobbs LG, Gonzalez R, Williams MC (1986) An improved method for isolating type II cells in high yield and purity. Am Rev Respir Dis 134: 141–145.
[31]
Baloglu E, Reingruber T, Bartsch P, Mairbaurl H (2011) beta2-Adrenergics in hypoxia desensitize receptors but blunt inhibition of reabsorption in rat lungs. Am J Respir Cell Mol Biol 45: 1059–1068.
[32]
Chen JT, Lin TS, Chow KC, Huang HH, Chiou SH, et al. (2006) Cigarette smoking induces overexpression of hepatocyte growth factor in type II pneumocytes and lung cancer cells. Am J Respir Cell Mol Biol 34: 264–273.
[33]
Abate W, Alghaithy AA, Parton J, Jones KP, Jackson SK (2010) Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains. J Lipid Res 51: 334–344.
[34]
Ikegami M, Scoville EA, Grant S, Korfhagen T, Brondyk W, et al. (2007) Surfactant protein-D and surfactant inhibit endotoxin-induced pulmonary inflammation. Chest 132: 1447–1454.
[35]
Thomassen MJ, Meeker DP, Antal JM, Connors MJ, Wiedemann HP (1992) Synthetic surfactant (Exosurf) inhibits endotoxin-stimulated cytokine secretion by human alveolar macrophages. Am J Respir Cell Mol Biol 7: 257–260.
[36]
Di Giuseppe M, Gambelli F, Hoyle GW, Lungarella G, Studer SM, et al. (2009) Systemic inhibition of NF-kappaB activation protects from silicosis. PLoS One 4: e5689.
[37]
Driscoll KE, Carter JM, Howard BW, Hassenbein D, Janssen YM, et al. (1998) Crocidolite activates NF-kappa B and MIP-2 gene expression in rat alveolar epithelial cells. Role of mitochondrial-derived oxidants. Environ Health Perspect 106 Suppl 5: 1171–1174.
[38]
Haddad JJ (2009) Thymulin and zinc (Zn2+)-mediated inhibition of endotoxin-induced production of proinflammatory cytokines and NF-kappaB nuclear translocation and activation in the alveolar epithelium: unraveling the molecular immunomodulatory, anti-inflammatory effect of thymulin/Zn2+ in vitro. Mol Immunol 47: 205–214.
[39]
Manzer R, Wang J, Nishina K, McConville G, Mason RJ (2006) Alveolar epithelial cells secrete chemokines in response to IL-1beta and lipopolysaccharide but not to ozone. Am J Respir Cell Mol Biol 34: 158–166.
[40]
Miura TA, Wang J, Mason RJ, Holmes KV (2006) Rat coronavirus infection of primary rat alveolar epithelial cells. Adv Exp Med Biol 581: 351–356.
[41]
Dobbs LG, Gonzalez R, Matthay MA, Carter EP, Allen L, et al. (1998) Highly water-permeable type I alveolar epithelial cells confer high water permeability between the airspace and vasculature in rat lung. Proc Natl Acad Sci U S A 95: 2991–2996.
[42]
Gonzalez R, Yang YH, Griffin C, Allen L, Tigue Z, et al. (2005) Freshly isolated rat alveolar type I cells, type II cells, and cultured type II cells have distinct molecular phenotypes. Am J Physiol Lung Cell Mol Physiol 288: L179–189.
[43]
Johnson MD, Widdicombe JH, Allen L, Barbry P, Dobbs LG (2002) Alveolar epithelial type I cells contain transport proteins and transport sodium, supporting an active role for type I cells in regulation of lung liquid homeostasis. Proc Natl Acad Sci U S A 99: 1966–1971.
[44]
Mason RJ, Williams MC (1977) Type II alveolar cell. Defender of the alveolus. Am Rev Respir Dis 115: 81–91.
[45]
Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER (1982) Cell number and cell characteristics of the normal human lung. Am Rev Respir Dis 126: 332–337.
[46]
Hortobagyi L, Kierstein S, Krytska K, Zhu X, Das AM, et al. (2008) Surfactant protein D inhibits TNF-alpha production by macrophages and dendritic cells in mice. J Allergy Clin Immunol 122: 521–528.
[47]
Yamazoe M, Nishitani C, Takahashi M, Katoh T, Ariki S, et al. (2008) Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J Biol Chem 283: 35878–35888.
[48]
Walker MG, Tessolini JM, McCaig L, Yao LJ, Lewis JF, et al. (2009) Elevated endogenous surfactant reduces inflammation in an acute lung injury model. Exp Lung Res 35: 591–604.
[49]
Jain D, Atochina-Vasserman EN, Tomer Y, Kadire H, Beers MF (2008) Surfactant protein D protects against acute hyperoxic lung injury. Am J Respir Crit Care Med 178: 805–813.
[50]
Kuronuma K, Mitsuzawa H, Takeda K, Nishitani C, Chan ED, et al. (2009) Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2. J Biol Chem 284: 25488–25500.
[51]
Hayden MS, Ghosh S (2004) Signaling to NF-kappaB. Genes Dev 18: 2195–2224.
[52]
Yamamoto K, Ferrari JD, Cao Y, Ramirez MI, Jones MR, et al. (2012) Type I alveolar epithelial cells mount innate immune responses during pneumococcal pneumonia. J Immunol 189: 2450–2459.
[53]
Matthaei KI (2007) Genetically manipulated mice: a powerful tool with unsuspected caveats. J Physiol 582: 481–488.
[54]
Schroeter M, Kury P, Jander S (2003) Inflammatory gene expression in focal cortical brain ischemia: differences between rats and mice. Brain Res Mol Brain Res 117: 1–7.
[55]
Barbarin V, Nihoul A, Misson P, Arras M, Delos M, et al. (2005) The role of pro- and anti-inflammatory responses in silica-induced lung fibrosis. Respir Res 6: 112.
[56]
Mestas J, Hughes CC (2004) Of mice and not men: differences between mouse and human immunology. J Immunol 172: 2731–2738.
[57]
Rosenberg GA, Estrada EY, Mobashery S (2007) Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: Differences in response based on strains and solvents. Brain Res 1133: 186–192.
[58]
Carter JM, Corson N, Driscoll KE, Elder A, Finkelstein JN, et al. (2006) A comparative dose-related response of several key pro- and antiinflammatory mediators in the lungs of rats, mice, and hamsters after subchronic inhalation of carbon black. J Occup Environ Med 48: 1265–1278.
